(177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Borderline Low and Discordant Renal Parameters: Treatment Feasibility Assessment by Sequential Estimation of Triple Parameters and Filtration Fraction

The aim was to assess the effect of standard fixed-dose protocol of (177)Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with borderline low renal function of one parameter (glomerular filtration rate [GFR], effective renal plasma flow [ERPF] or serum creatinine), that was disco...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Chinna, Basu, Sandip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778708/
https://www.ncbi.nlm.nih.gov/pubmed/29398960
http://dx.doi.org/10.4103/wjnm.WJNM_94_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778708/
https://www.ncbi.nlm.nih.gov/pubmed/29398960
http://dx.doi.org/10.4103/wjnm.WJNM_94_16

Ejemplares similares